The decrease in total expenses during the three months ended September 30, 2025 versus the same period in 2024 was primarily due to a $313,000 decrease in the capital gains incentive fee expense, a $219,590 decrease in interest expense, a $124,883 decrease in base management fee expense, and a $111,713 decrease in the income based incentive fee expense.
The capital gains incentive fee expense during the three months ended September 30, 2025 is due to the calculation of the capital gains fee as required by GAAP. We are required under GAAP to accrue capital gains incentive fees on the basis of net realized capital gains and losses and net unrealized gains and losses. Our capital gains incentive fee accrual reflects the capital gains incentive fees that would be payable to RCM if our entire investment portfolio was liquidated at its fair value as of the balance sheet date, even though RCM is not entitled to this capital gains incentive fee under the Investment Management Agreement with respect to unrealized gains unless and until such gains are realized. At September 30, 2025, no fee would be due based on net portfolio depreciation, and accordingly no capital gains incentive fee expense was recognized during the three months ended September 30, 2025. For the three months ended September 30, 2024, the capital gains incentive fee expense was $313,000.
The decrease in interest expense resulted from lower average outstanding debt balances under the Credit Facility during the three months ended September 30, 2025 versus the same period in 2024. Interest expense for the three months ended September 30, 2025 and 2024 was $25,416 and $245,006, respectively.
The base management fee payable to RCM under the Investment Management Agreement is calculated based upon total assets less cash, and, as investments are exited or repaid, the base management fee payable to RCM will decrease accordingly. The base management fee expense for the three months ended September 30, 2025 and 2024 was $184,382 and $309,265, respectively.
The income based incentive fee is calculated quarterly in accordance with the Investment Management Agreement. The income based incentive fees accrued during the three months ended September 30, 2025 and 2024 was $66,505 and $178,218, respectively, and is a result of Pre-Incentive Fee Net Investment Income above the applicable hurdle rate during the applicable quarter, as set forth and described in the Investment Management Agreement. “Pre-Incentive Fee Net Investment Income” means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during such calendar quarter, minus our operating expenses for such calendar quarter (including the Base Management Fee, expenses payable under the Administration Agreement, and any interest expense and dividends paid on any issued and outstanding preferred stock, but excluding any portion of the Incentive Fee). Pre-Incentive Fee Net Investment Income includes any accretion of original issue discount, market discount, payment-in-kind interest, payment-in-kind dividends or other types of deferred or accrued income, including in connection with zero coupon securities, that we have recognized in accordance with GAAP, but have not yet received in cash (collectively, “Accrued Unpaid Income”). Pre-Incentive Fee Net Investment Income does not include any realized capital gains, realized and unrealized capital losses or unrealized capital appreciation or depreciation.
Net Investment Income
The excess of investment income over total expenses, including income taxes, represents net investment income. The net investment income for the three months ended September 30, 2025 and 2024 was $992,579 and $887,035, respectively.
Realized (Loss) Gain on Investments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September 30, 2025 |
|
|
Three months ended September 30, 2024 |
|
|
Change |
|
Realized (loss) gain on investments before income taxes |
|
$ |
(2,927,329 |
) |
|
$ |
7,230,082 |
|
|
$ |
(10,157,411 |
) |
During the three months ended September 30, 2025, we recognized a net realized loss of ($2,850,015) on the liquidation of our investment in Tilson. Tilson filed a voluntary petition for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court, District of Delaware, and subsequently sold all of its assets.
In addition, during the three months ended September 30, 2025, we recognized a net realized loss of ($77,314) on our loan investment in Lumious.
During the three months ended September 30, 2024, we sold our investment in SciAps and recognized a realized gain of $7,699,879. In addition, during the three months ended September 30, 2024, we liquidated our investment in Mezmeriz, Inc. (Mezmeriz), which was previously valued at $0, and recognized a realized loss of ($742,850). We also recognized a realized gain of $23,699 from additional proceeds received from DSD Operating, LLC (DSD), an investment we exited during 2023.